secwatch.observer — SEC 8-K summary
======================================

Issuer:     Serina Therapeutics, Inc. (SER)
CIK:        0001708599
Form:       8-K
Filed at:   2024-12-18T23:59:59+00:00
Accession:  0001708599-24-000029
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Serina shareholders approve equity plan amendment increasing share reserve by 950,000 shares
--------------------------------------------------------------------------------

- Shareholders approved Amendment to 2024 Equity Incentive Plan, increasing shares reserved by 950,000 to 2,675,000.
- Amendment also provides for automatic annual share increase of 5% of outstanding shares from FY2026 through FY2034.
- Directors elected: Balkrishan 'Simba' Gill (5,998,349 votes), Remy Gross (5,963,359), Steven Mintz (5,953,931).
- Ratification of Frazier & Deeter as independent auditors approved with 7,162,782 votes for, 90,321 against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1708599/000170859924000029/0001708599-24-000029-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1708599/000170859924000029/ser-20241213.htm
  HTML page:      https://secwatch.observer/filing/0001708599-24-000029

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer